dobutamine has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloomfield, SA; Hogan, HA; Swift, JM | 1 |
1 other study(ies) available for dobutamine and Bone Loss, Osteoclastic
Article | Year |
---|---|
β-1 adrenergic agonist mitigates unloading-induced bone loss by maintaining formation.
Topics: Absorptiometry, Photon; Adrenergic beta-1 Receptor Agonists; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Dobutamine; Hindlimb Suspension; Male; Osteogenesis; Rats; Rats, Sprague-Dawley; Tibia; Tomography, X-Ray Computed | 2013 |